Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.
第二線降血糖藥物對心血管結果的比較效果：LEGEND-T2DM的多國聯合分析。
J Am Coll Cardiol 2024-08-28
Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
DPP-4抑制劑、GLP-1受體激動劑、SGLT-2抑制劑和磺脲類藥物對第2型糖尿病患者死亡率、心血管和腎臟結果的影響：基於網絡荟萃分析的方法。
Diabet Med 2023-11-16
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records.
SGLT2抑制劑、GLP-1受體激動劑、DPP-4抑制劑和磺醯脲對主要不良心血管事件風險的比較有效性：使用電子健康記錄模擬隨機目標試驗。
Lancet Diabetes Endocrinol 2023-09-28
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.
LEGEND-T2DM 中各心血管風險群體第二線抗高血糖藥物啟動的跨國模式：聯邦藥物流行病學評估。
BMJ Med 2024-03-30
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.
第二型糖尿病患者合併輕至中度慢性腎臟疾病時，鈉葡萄糖共同轉運蛋白2抑制劑與葡萄糖樣肽-1受體激動劑的比較效果。
Diabetes Obes Metab 2024-03-14
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study.
第二線抗高血糖藥物對心血管結果的比較效果：LEGEND-T2DM研究的大規模、跨國、聯合分析。
medRxiv 2024-04-09
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
第二線口服抗糖尿病藥物在2型糖尿病患者中的比較有效性：使用常規收集的健康數據模擬目標試驗。
BMJ 2024-05-08
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis.
第三步葡萄糖降低藥物中鈉-葡萄糖共同轉運蛋白2抑制劑和葡萄糖樣肽1受體激動劑對2型糖尿病患者心血管和死亡益處的回顧性cohort分析。
BMJ Open Diabetes Res Care 2024-05-08
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes.
糖尿病患者第二線治療中磺胺脲類藥物與新型糖尿病藥物的效果和成本效益比較。
BMJ Open Diabetes Res Care 2024-05-27
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk.
2 型糖尿病患者中度心血管風險患者心血管結果的降糖藥物有效性。
Nat Cardiovasc Res 2024-06-07
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
SGLT2 抑制劑與 GLP-1 受體激動劑在 2 型糖尿病中的腎臟與心血管效果比較。
J Am Coll Cardiol 2024-08-14